Collectively, these results indicate that folate–miR-34a, as expected, inhibited the growth of FOLR1-expressing breast, cervical, and ovarian cancer cells but, unexpectedly, did not exhibit any inhibitory effects on PCa cells. This evidence concerns the gene FOLR1 and ovarian cancer.